Gapping up
In reaction to earnings/guidance:
- ADBE +4.7%, NUE +0.4% (guides Q2 earnings above consensus)
Other news:
- SPCE +39.7% (starts commercial spaceline operations; first spaceflight to occur this month)
- NETI +13.2% (Eneti and Cadeler A/S sign business combination agreement to create a leading offshore wind turbine and foundation installation company)
- ENVX +9.3% (achieves Q2 forecast for units made at Fab1 location)
- OTLY +4.1% (files for 22424755 ADSs by selling shareholders)
- SQSP +4% (SQSP to acquire assets associated with GOOG Domains business)
- AUTL +3.5% (presents positive results from AUTO4 in relapsed/refractory TRBC1-positive peripheral t-cell lymphoma)
- DLO +3% (says it had positive talks with Argentine govt)
- TSP +3% (becomes first to successfully operate driver out fully autonomous semi-truck on open public roads in China)
- LXRX +2.7% (FDA approves INPEFA)
- COIN +2.2% (BLK iShares unit files for the formation of a spot Bitcoin ETF)
- IPHA +2.1% (Highlights Increased Lacutamab Clinical Activity From Interim Results of Phase 2 TELLOMAK Study With Updated Olsen Criteria)
- XAIR +1.8% (licenses commercial rights to nNOS Inhibitors)
- RETA +1.8% (receives FDA Filing Acceptance of SKYCLARYS NDA prior approval supplement)
- NVAX +1.7% (to Deliver Protein-based Monovalent XBB COVID Vaccine)
- SSRM +1.5% (announces new normal course issuer bid)
- QGEN +1.3% (publication of review highlighting value of its TB testing technology)
- STLA +1% (will offer EVs at under €25000 early next year according to Bloomberg)
Analyst comments:
- ABCM +3.4% (upgraded to Buy from Neutral at BofA Securities)
- WST +1% (upgraded to Buy from Neutral at BofA Securities)